MARKET

GSK

GSK

GSK PLC
NYSE
48.29
-0.42
-0.86%
After Hours: 48.07 -0.22 -0.45% 17:19 12/18 EST
OPEN
48.40
PREV CLOSE
48.71
HIGH
48.69
LOW
48.24
VOLUME
3.22M
TURNOVER
--
52 WEEK HIGH
49.44
52 WEEK LOW
30.40
MARKET CAP
98.47B
P/E (TTM)
13.46
1D
5D
1M
3M
1Y
5Y
1D
GSK: 2026 Looks Good
Seeking Alpha · 1h ago
TD Cowen Remains a Hold on GlaxoSmithKline (GSK)
TipRanks · 7h ago
BUZZ-CAMP4 Therapeutics drops after $30 mln stock sale, GSK deal
Reuters · 9h ago
Camp4 Therapeutics, GSK enter strategic collaboration
TipRanks · 10h ago
CAMP4 THERAPEUTICS - UNDER DEAL WITH GSK, ELIGIBLE FOR UP TO $440 MLN IN MILESTONE PAYMENTS - SEC FILING
Reuters · 10h ago
CAMP4 THERAPEUTICS CORP: UNDER TERMS OF AGREEMENT, CAMP4 WILL RECEIVE $17.5 MLN CASH UPFRONT PAYMENT
Reuters · 10h ago
UPDATE 3-AbbVie, several other pharma companies near MFN deal with Trump, sources say
Reuters · 1d ago
More pharmas expected to sign drug pricing deals with Trump on Friday - report
Seeking Alpha · 1d ago
More
About GSK
GSK plc is a biopharma company. The Company’s segments include Commercial Operations and Research and Development. Its portfolio and pipeline are focused on developing medicines and vaccines in four core therapeutic areas, which are the areas of human health it focuses on to prevent and treat disease: respiratory, immunology and inflammation; oncology; human immunodeficiency virus (HIV), and infectious diseases. Its specialty medicines prevent and treat diseases, from HIV to respiratory diseases, immune-mediated conditions like lupus, and cancer. Its vaccine portfolio includes over 20 vaccines to protect people from diseases and infections throughout their lives. General medicines include inhaled medicines for asthma and COPD to antibiotics. It develops and commercializes preclinical antibody-drug conjugate for Metastatic castration-resistant prostate cancer. Its portfolio also includes Efimosfermin, a fibroblast growth factor 21 (FGF21) analog therapeutic in clinical development.

Webull offers GSK plc (ADR) stock information, including NYSE: GSK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GSK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GSK stock methods without spending real money on the virtual paper trading platform.